- 1 of 1264
- ››
- 1 of 26
- ››
Browse all recent literature including hourly updates
| Name | Affiliation | Citation Score |
|---|---|---|
| Dr. CA Mirkin | Department of Chemistry and Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113. | 76364 |
| Dr. Y Xia | Department of Chemistry, University of Washington, Seattle, WA 98195, USA. | 47390 |
| Dr. CM Lieber | Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA. | 43444 |
| Dr. ZL Wang | State Key Laboratory of Crystal Materials, Shandong University, Jinan 250100, P. R. China. | 39683 |
| Dr. AP Alivisatos | Department of Chemistry, University of California, Berkeley, CA 94720, USA. | 38690 |
| Dr. W Tan | Department of Chemistry, Center for Research at Bio/nano Interface, Shands Cancer Center, UF Genetics Institute, McKnight Brain Institute, NSF Partic | 36489 |
| Dr. H Dai | hemistry, Stanford University, Stanford, California 94305, USA. | 35457 |
| Dr. I Willner | Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel. | 34647 |
| Dr. Y Lin | Chief Scientist Pacific Northwest Natioal Laboratory | 31629 |
| Dr. R Weissleder | Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129-2060. | 31270 |
| Dr. S Dong | State Key Laboratory of Electroanalytic Chemistry, Changchun Institute of Applied Chemistry, Graduate School of the Chinese Academy of Sciences, Chang | 30587 |
| Dr. C Dekker | Kavli Institute of Nanoscience, Delft University of Technology, Lorentzweg 1, 2628 CJ Delft, The Netherlands. | 30176 |
| Dr. P Couvreur | UMR CNRS 8612 Physico-chimie, Pharmacotechnie, Biopharmacie--Université de Paris-Sud, Châtenay-Malabry, France. | 28800 |
| Dr. F Besenbacher | Interdisciplinary Nanoscience Center (iNANO) and Department of Physics and Astronomy, University of Aarhus, DK-8000 Aarhus C, Denmark. | 28669 |
| Dr. RW Murray | Kenan Laboratories of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA. | 28262 |
| Dr. S Nie | Department of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30322, USA. | 27203 |
| Dr. LP Kouwenhoven | Kavli Institute of Nanoscience, Delft University of Technology, P.O. Box 5046, 2600 GA Delft, The Netherlands. | 26596 |
| Dr. H Yan | Department of Computer Science, Duke University, Durham, North Carolina 27708, USA. | 26470 |
| Dr. TJ Webster | Weldon School of Biomedical Engineering, Purdue University, 500 Central Drive, West Lafayette, IN 47907-2022, USA. | 26152 |
| Dr. SI Stupp | 26075 | |
| Dr. JF Stoddart | California NanoSystems Institute, Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095-1569, USA. | 25513 |
| Dr. PM Ajayan | Engineering, Rensselaer Polytechnic Institute, Troy, New York 12180, USA. | 25456 |
| Dr. S Iijima | 25387 | |
| Dr. T Aida | 25264 | |
| Dr. L Jiang | Laboratory of Organic Solids, Chinese Academy of Sciences, Beijing, 100080, People\\\'s Republic of China. | 24546 |
Browse all laboratories
| Job title | Employer |
Posting date |
|---|---|---|
| Senior Research Scientist | Nanoink | 09/02/2010 |
| Assistant/Associate/Full Professor | USDA IL | 09/01/2010 |
| Post-doc for biological screening of functional polymers | Friedrich Schiller University | 09/01/2010 |
| PhD in supramolecular chemistry / nanotechnology | Leiden University | 09/01/2010 |
| New Fellowship Opportunities | CEA | 09/01/2010 |
| Leading Scientist / Full Professor (W3) | Universität Hamburg | 09/01/2010 |
| Nanopower System Engineer/Scientist | Mitre | 09/01/2010 |
| Physician Scientist - Area of Allergy Diseases | 09/01/2010 | |
| Post-doctoral position CEA | CEA Grenoble | 09/01/2010 |
| Postdoctoral Associate - Physics | Virginia Tech | 08/31/2010 |
- 1 of 98
- ››
| Job title | Employer | Posting date |
|---|---|---|
| Postdoc in nanomedicine | Aahus University, iNANO | 08/23/2010 |
| Post-doctoral position in Metal-Semiconductor Nanocomposite Solar Cells (MSNSC) | ICFO - The Institute of Photonic Sciences | 08/24/2010 |
| Nanomedicine / Biophotonics PhD opportunity – Therapeutics Research Centre | University of South Australia (UniSA) | 08/23/2010 |
| Post-Doctoral Researcher | CSIR | 08/24/2010 |
| 7 PhD positions and 2 PostDoc positions | Helmholtz Centre Potsdam - GFZ German Research Centre for Geosciences - Helmholtz Association | 08/17/2010 |
| Postdoctoral Associate | Massachusetts Institute of Technology | 08/28/2010 |
| Postdoctoral Position in Organometallic Chemistry + Nanoscience | University of Georgia, Athens, Georgia, USA | 08/28/2010 |
| Research Scientist | IBM | 08/25/2010 |
| Postdoctoral Research Associate | University of Minnesota Twin Cities | 08/27/2010 |
| Functional / Cellular Immunology Postdoctoral Fellow | Brigham & Women's Hospital, Harvard Medical School | 08/19/2010 |
- 1 of 21
- ››
|
Posted Aug 19, 2010 by Christian Hesketh
|
What is nanomedicine? |
Posted Aug 19, 2010 by Christian Hesketh |
|
Nanomedicine is the medical application of nanotechnology that will hopefully lead to useful research tools, advanced drug delivery systems, and new ways to treat disease or repair damaged tissues and cells. Drug delivery is currently the most advanced application of nanotechnology in medicine. Nanoscale particles are being developed to improve drug bioavailability, a major limitation in the design of new drugs. Poor bioavailability is especially problematic with newer and still experimental RNA interference therapy. |
What is nanomedicine? |
Posted Aug 19, 2010 by Christian Hesketh |
|
Nanomedicine is the medical application of nanotechnology that will hopefully lead to useful research tools, advanced drug delivery systems, and new ways to treat disease or repair damaged tissues and cells. Drug delivery is currently the most advanced application of nanotechnology in medicine. Nanoscale particles are being developed to improve drug bioavailability, a major limitation in the design of new drugs. Poor bioavailability is especially problematic with newer and still experimental RNA interference therapy. |
-
Please call me at 310
-
Hi Rob I am looking for used
-
Hi, i'm in agreement with all
-
Here is the picture
-
Thanks RaphC, a small little
more
| Name of conference |
Conference dates |
Location |
|---|---|---|
| RNAi & miRNA Europe | 09/14/2010 - 09/15/2010 |
Dublin
Ireland
|






